+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Aciphex"

Aciphex - API Insight, 2022 - Product Thumbnail Image

Aciphex - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Aciphex- Drug Insight, 2019 - Product Thumbnail Image

Aciphex- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Aciphex (rabeprazole sodium) is a proton pump inhibitor (PPI) used to treat gastroesophageal reflux disease (GERD) and other gastrointestinal disorders. It works by reducing the amount of acid produced in the stomach, which helps to relieve symptoms such as heartburn, difficulty swallowing, and persistent cough. Aciphex is also used to treat conditions such as erosive esophagitis, Zollinger-Ellison syndrome, and Helicobacter pylori infection. Aciphex is part of a larger market of gastrointestinal drugs, which includes other PPIs such as Nexium, Prilosec, and Prevacid, as well as H2 blockers like Zantac and Pepcid. These drugs are used to treat a variety of gastrointestinal conditions, including GERD, peptic ulcers, and gastritis. The companies in the Aciphex market include Eisai Co., Ltd., AstraZeneca, and Takeda Pharmaceuticals. Show Less Read more